Not Available

Registry ID

EUCTR2010-022520-73

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Hellenic Oncology Research Group

Start date

2011-07-12

Completion date

2015-12-17

Last update

2026-08-16

Conditions

• Early breast cancer (primary operable HER2-negative breast cancer)

Summary

To evaluate the preliminary antitumor activity in terms of pathological complete sponses (pCR) of bevacizumab in combination with dose-dense chemotherapy.

Locations

• , , Greece

View on source registry